Android app on Google Play

UPDATE: Vanda Pharmaceuticals (VNDA) Opens Higher; Lazard Raises PT to $17

May 17, 2013 9:44 AM EDT Send to a Friend
Get Alerts VNDA Hot Sheet
Price: $14.74 --0%

Rating Summary:
    5 Buy, 0 Hold, 0 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 17 | Down: 18 | New: 2
Trade VNDA Now!
Join SI Premium – FREE
(Updated - May 17, 2013 9:49 AM EDT)

Lazard Capital today maintained a Buy rating on Vanda Pharmaceuticals (NASDAQ: VNDA) and raised its price target to $17.00 (from $11.00). Shares opened noticeably higher and are on the move early on Friday.

Update: Analysts cited positive checks from sleep specialists on tasimelteon for non-24 hour disorder.

For an analyst ratings summary and ratings history on Vanda Pharmaceuticals click here. For more ratings news on Vanda Pharmaceuticals click here.

Shares of Vanda Pharmaceuticals closed at $5.50 yesterday.




You May Also Be Interested In


Related Categories

Analyst Comments, Analyst PT Change, Trader Talk

Related Entities

Lazard

Add Your Comment